Vulcan Energy: Reading the Drill Data and the Disclosure Filings Side by Side

Two separate disclosures landed on Vulcan Energy's desk within weeks of each other, and they tell very different stories. One is a drilling result from the company's Lionheart lithium project. The other is a regulatory filing from Citigroup. Investors who conflate the two risk misreading both.

The thread that connects them is a single principle: what gets measured on site and what gets reported on paper are not the same thing, and neither one substitutes for the other.

A test result, not a production guarantee

Vulcan has wrapped up and tested the seventh of 28 planned wells at Lionheart. The well, designated LSC-3a, was drilled horizontally in September and marks the first time the company has attempted to reinject lithium-depleted brine into the sandstone matrix rather than into a fault zone.

During testing, the well achieved an injection rate of roughly 35 standard liters per second. Modelling based on the borehole data points to a capacity of about 64 standard liters per second under the operating conditions Vulcan has planned. For comparison, the field development plan assumes approximately 40 standard liters per second for matrix injection wells of this type.

That gap between the measured figure and the modelled one deserves attention. The two numbers describe different circumstances — one is what happened during a test, the other is what the company projects will happen during sustained operations. The higher modelled capacity is not evidence of proven continuous injection performance. What it does is lend weight to the technical premise that the reinjection concept can work as designed.

What the data feeds into next

According to the company, every well tested so far has met or exceeded the assumptions laid out in the field development plan. LSC-3a adds a fresh dimension to that record by supplying insights into matrix reinjection specifically.

The practical payoff lies downstream. Data from this test will guide work on the next two wells, LSC-4 and LSC-5. A single test result thus becomes a foundation for subsequent drilling. What it does not deliver is a concrete cost saving or a faster timeline — neither can be inferred from the result.

Lionheart's stated targets remain unchanged: 24,000 tonnes of lithium hydroxide monohydrate per year, alongside 275 gigawatt-hours of renewable electricity for internal use and 560 gigawatt-hours of heat. The successful reinjection test touches one technical building block of that plan. It is neither proof of lithium hydroxide production nor a revised economic forecast. Its value is narrower — it gives the drilling programme more measurement data to work with and reinforces existing assumptions about reinjection.

A stake increase that isn't a stake increase

Separately, Citigroup filed a higher notifiable interest in Vulcan Energy on Friday. The headline figure moved from 7.1056% to 8.1917%. But the nature of the change matters more than its size: the mandatory disclosure cites securities lending and contracts from ordinary market business.

That means the increase cannot simply be read as Citigroup building a direct equity position. The lending transactions and market contracts form the backdrop to the reported voting interests. No strategic intent to accumulate a stake can be deduced from the change alone, nor does it say anything about how Lionheart is progressing.

The filing concerns the allocation of voting rights and participation interests. It is not an operational update, and it does not stand in for information about the lithium project's execution.

VULSORB production: preparation, not operation

For an actual operational reference point, investors can look to the start of commercial production of Vulcan's own adsorbent, VULSORB, in Germany — announced roughly three weeks ago. The first output is earmarked for the initial filling of Lionheart's lithium extraction columns, with commissioning of the plant scheduled for the second half of 2028.

Vulcan says producing the adsorbent in-house should help reduce technology, supply chain and project execution risks. That is the company's own assessment of the benefit. Manufacturing the adsorbent is a distinct step from commissioning Lionheart itself.

For shareholders, the significance lies in the preparation: Vulcan is making material that will later go into the extraction columns. The start of production does not mean Lionheart is already up and running.

Keeping the threads apart

Until Lionheart is commissioned, the different disclosures should not be blended together. The Citigroup filing describes notifiable participation interests. The VULSORB production concerns project preparation. The drilling test at LSC-3a sits somewhere in between — a technical milestone that informs future wells without proving commercial output.

The next scheduled occasion to assess Vulcan's operational trajectory against fresh company disclosures is the upcoming quarterly report.